Authors: Nobilis, M Pour, M Kunes, J Kopecky, J Kvetina, J Svoboda, Z Sladkova, K Vortel, J

Citation: M. Nobilis et al., High-performance liquid chromatographic determination of ursodeoxycholic acid after solid phase extraction of blood serum and detection-oriented derivatization, J PHARM B, 24(5-6), 2001, pp. 937-946

Authors: Anzenbacherova, E Anzenbacher, P Macek, K Kvetina, J

Citation: E. Anzenbacherova et al., Determination of enzyme (angiotensin convertase) inhibitors based on enzymatic reaction followed by HPLC, J PHARM B, 24(5-6), 2001, pp. 1151-1156

Authors: Anzenbacherova, E Anzenbacher, P Perlik, F Kvetina, J

Citation: E. Anzenbacherova et al., Use of a propafenone metabolic ratio as a measure of CYP2D6 activity, INT J CL PH, 38(9), 2000, pp. 426-429

Authors: Bajgar, J Skopec, F Herink, J Patocka, J Kvetina, J

Citation: J. Bajgar et al., Effect of 7-methoxytacrine and L-carnitine on the activity of choline acetyltransferase, GEN PHYSL B, 18, 1999, pp. 3-6

Authors: Kvetina, J Svoboda, Z Nobilis, M Pastera, J Anzenbacher, P

Citation: J. Kvetina et al., Experimental goettingen minipig and beagle dog as two species used in bioequivalence studies for clinical pharmacology (5-aminosalicylic acid and atenolol as model drugs), GEN PHYSL B, 18, 1999, pp. 80-85